CLINICAL TRIALS PROFILE FOR AZMACORT
✉ Email this page to a colleague
All Clinical Trials for AZMACORT
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00000569 ↗ | Lung Health Study II | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 1993-09-01 | To determine if participants with chronic obstructive pulmonary disease, who were assigned to inhaled corticosteroids had a lower rate of decline in lung function and lower incidence of respiratory morbidity compared to participants assigned to placebo. |
NCT00000569 ↗ | Lung Health Study II | Completed | University of Minnesota | Phase 3 | 1993-09-01 | To determine if participants with chronic obstructive pulmonary disease, who were assigned to inhaled corticosteroids had a lower rate of decline in lung function and lower incidence of respiratory morbidity compared to participants assigned to placebo. |
NCT00000569 ↗ | Lung Health Study II | Completed | University of Minnesota - Clinical and Translational Science Institute | Phase 3 | 1993-09-01 | To determine if participants with chronic obstructive pulmonary disease, who were assigned to inhaled corticosteroids had a lower rate of decline in lung function and lower incidence of respiratory morbidity compared to participants assigned to placebo. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for AZMACORT
Condition Name
Clinical Trial Locations for AZMACORT
Trials by Country
Clinical Trial Progress for AZMACORT
Clinical Trial Phase
Clinical Trial Sponsors for AZMACORT
Sponsor Name